Frederick Durand is a National Lead in Medical Affairs for Rheumatology at Eli Lilly and Company, having recently transitioned into this role in 2023. Their prior experiences include serving as Medical Director for late-phase immunology and as a Medical Advisor within the International Business Unit for Dermatology, where they coordinated international prelaunch activities for treatments related to various dermatological conditions. Previously, they held the position of Medical Lead for Rheumatology in France, overseeing the launch of multiple medications for rheumatoid arthritis and other conditions. Frederick holds a Master of Business Administration from HEC School of Management, as well as a medical degree from Université Pierre et Marie Curie, complemented by a diploma in clinical trial analysis from Université Claude Bernard Lyon 1.
This person is not in any teams
This person is not in any offices